quinapyramine: RN given refers to hydride; structure
ID Source | ID |
---|---|
PubMed CID | 122993 |
CHEMBL ID | 1398609 |
SCHEMBL ID | 291197 |
SCHEMBL ID | 14286196 |
MeSH ID | M0047436 |
Synonym |
---|
nsc-48223 |
NCI60_004145 |
n6-(2-imino-1,6-dimethyl-1,2-dihydro-4-pyrimidinyl)-1,2-dimethyl-15-quinoline-4,6-diamine |
antrycide |
quinolinium, 4-amino-6-[(2-amino-1,6-dimethyl-4(1h)-pyrimidinylidene)amino]-1,2-dimethyl- |
23609-65-6 |
6-[(e)-(2-amino-1,6-dimethyl-pyrimidin-4-ylidene)amino]-1,2-dimethyl-quinolin-1-ium-4-amine |
quinapyramine |
NSC48223 , |
NCGC00013591 |
NCI48223 |
4-amino-6-((2-amino-1,6-dimethyl-4-pyrimidinyl)amino)-1-methylquinaldinium ion |
quinolinium, 4-amino-6-((2-amino-1,6-dimethyl-4(1h)-pyrimidinylidene)amino)-1,2-dimethyl-, conjugate monoacid |
NCISTRUC2_001482 |
NCISTRUC1_001223 |
NCGC00096704-01 |
CCG-36923 |
NCGC00013591-02 |
quinapyramine cation |
20493-41-8 |
quinapyramine ion |
b2nt1100wr , |
unii-b2nt1100wr |
quinolinium, 4-amino-6-((1,2-dihydro-2-imino-1,6-dimethyl-4-pyrimidinyl)amino)-1,2-dimethyl- |
quinapyramine [mi] |
1082114-38-2 |
SCHEMBL291197 |
SCHEMBL14286196 |
CHEMBL1398609 |
6-[(2-amino-1,6-dimethylpyrimidin-4-ylidene)amino]-1,2-dimethylquinolin-1-ium-4-amine |
Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
15-lipoxygenase, partial | Homo sapiens (human) | Potency | 7.9433 | 0.0126 | 10.6917 | 88.5700 | AID887 |
nonstructural protein 1 | Influenza A virus (A/WSN/1933(H1N1)) | Potency | 0.7943 | 0.2818 | 9.7212 | 35.4813 | AID2326 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 50 (62.50) | 18.7374 |
1990's | 13 (16.25) | 18.2507 |
2000's | 5 (6.25) | 29.6817 |
2010's | 10 (12.50) | 24.3611 |
2020's | 2 (2.50) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 3 (3.70%) | 6.00% |
Case Studies | 1 (1.23%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 77 (95.06%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Article | Year |
---|---|
Cytotoxicity and genotoxicity of a trypanocidal drug quinapyramine sulfate loaded-sodium alginate nanoparticles in mammalian cells. International journal of biological macromolecules, Volume: 88 | 2016 |
In vitro activity and preliminary toxicity of various diamidine compounds against Trypanosoma evansi. Veterinary parasitology, May-11, Volume: 169, Issue: 3-4 | 2010 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Article | Year |
---|---|
In vivo and in vitro sensitivity of Trypanosoma evansi and T. equiperdum to diminazene, suramin, MelCy, quinapyramine and isometamidium. Acta tropica, Volume: 50, Issue: 2 | 1991 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Article | Year |
---|---|
Studies of quinapyramine-resistance of Trypanosoma brucei evansi in China. Acta tropica, Volume: 116, Issue: 3 | 2010 |
Development and application of an antibody-ELISA to follow up a Trypanosoma evansi outbreak in a dromedary camel herd in France. Veterinary parasitology, Jun-10, Volume: 162, Issue: 3-4 | 2009 |
Resistance to drug by different isolates Trypanosoma evansi in China. Acta tropica, Volume: 90, Issue: 3 | 2004 |
Drug resistance in Sudanese Trypanosoma evansi. Veterinary parasitology, Jan-28, Volume: 80, Issue: 4 | 1999 |
In vivo and in vitro sensitivity of Trypanosoma evansi and T. equiperdum to diminazene, suramin, MelCy, quinapyramine and isometamidium. Acta tropica, Volume: 50, Issue: 2 | 1991 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |